Concerns about the supply of pharmaceuticals to Northern Ireland

29 Oct 2020 02:44 PM

The EU Environment Sub-Committee writes to Edward Agar MP, Minister at the Department for Health and Social Care with their concerns for the supply of pharmaceuticals to Northern Ireland from 1 January 2020.

Image representing news article

Background

Approximately 98% of the medicines used in Northern Ireland are imported either from or via Great Britain, often originating in the EU. As of 1 January 2021 one of the EU laws regarding medicinal products, the Falsified Medicines Directive (FMD), which aims to prevent counterfeit medicines entering the supply chain and applies to the majority of prescription-only medicines, will apply in Northern Ireland but not in Great Britain. This creates uncertainty and worry for pharmaceutical companies about what rules will apply to medicines imported via Great Britain.
The Committee have serious concerns about the risk to the supply of prescription medicines in Northern Ireland from 1 January next year and have written asking for an urgent response on the following:

Further information